TSX-V:SBIO - CA78570Q1081 - Common Stock
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 52.34M | 49.60M | 35.95M | 42.31M | 24.22M | |||
Cost Of Goods | 19.92M | 18.98M | 14.17M | 16.96M | 9.66M | |||
Gross Profit | 32.42M | 30.63M | 21.78M | 25.35M | 14.56M | |||
Operating Expenses | 30.54M | 28.47M | 25.50M | 25.58M | 14.21M | |||
Research and Development | 6.68M | 5.76M | 4.70M | 5.32M | 2.77M | |||
Selling, General, and Administrative Expenses | 23.12M | 21.92M | 20.04M | 19.55M | 10.54M | |||
Operating Income | 1.88M | 2.16M | -3.72M | -234.00K | 345.40K | |||
Interest Income/Expense | -1.27M | -1.29M | -1.05M | -417.40K | -1.38M | |||
Other Income/Expense | N/A | N/A | 0.00 | -156.80K | -1.72M | |||
Non Recurring Items | N/A | -935.60K | N/A | 0.00 | 2.17M | |||
Income Before Taxes | -349.50K | -69.30K | -4.77M | -808.10K | -576.90K | |||
Income Tax | 42.40K | 41.60K | -8.40K | 38.60K | 6.90K | |||
Net Income | -392.00K | -110.90K | -4.76M | -846.80K | -583.80K | |||
EBITDA | 2.72M | 3.04M | -2.96M | 482.50K | 1.25M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.01 | -0.00 | -0.10 | -0.02 | -0.02 | |||
Non GAAP EPS | 0.01 | 0.01 | N/A | N/A | N/A | |||
Statistics | ||||||||
Gross Profit Margin | 61.95% | 61.75% | 60.58% | 59.92% | 60.12% | |||
Profit Margin | -0.75% | -0.22% | -13.25% | -2.00% | -2.41% | |||
Operating Profit Margin | 3.59% | 4.35% | -10.36% | -0.55% | 1.43% |
All data in USD